|This message contains images. If you don't see images, click here to view.|
Advertise in this news brief.
The ASHI website has been updated with the ASHI 2014-15 Board of Directors
New members include: Anat R. Tambur, DMD, Ph.D., D(ABHI), Doreen A. Jezek, MS, CHS, MB(ASCP)CM, Brian Duffy, MA, CHS, Sharon Adams, MT(ASCP), CHS(ABHI), Susan Saidman, Ph.D., D(ABHI), Medhat Z. Askar, M.D., Ph.D., D(ABHI) and Ruby Siegel, MS, CHS. These volunteers were elected to follow the vision and mission of ASHI and to work towards accomplishing our strategic goals.
| Share this article:
Renew your membership!
Renewing online is easy!
Go to the ASHI website.
Click on "Members Only" at the top of the page. Enter your username and password.
Username: first initial/last name
Password: member number
Review your contact and demographic information for accuracy. Then just click on “Renew Online.” If you would like a pre-populated, printed copy of your membership dues invoice, just log-in as usual, and print out the renewal pages. Once printed, please mail or fax your completed renewal form with credit card information or check payable to ASHI.
The 2015 ASHI Proficiency Testing Program brochures will be mailed soon
Online ordering will be available by the end of November.
The Kidney Allocation System: Question and answer town hall recording now available
The recording lasts approximately 1 hour 2 minutes and can be accessed here.
Abstract submission and registration for the FOCIS 2015 meeting is open
FOCIS is the meeting in translational immunology that will give you a competitive edge in your career. FOCIS 2015 will be held June 24-27, at the Hilton San Diego Bayfront in San Diego, California.
ASHI's 40th Annual Meeting in Denver was a huge success!
Click here for pictures.
The frequency of HLA-B*57:01 and the risk of abacavir hypersensitivity reactions in the majority population of Costa Rica
HLA-B∗57:01 is a well-known and cost-effective pharmacogenetic marker for abacavir hypersensitivity. As with other HLA alleles, there is widespread variation in its frequency across populations. The Costa Rica Central Valley Population (CCVP) is the major population in this country. The frequency of HLA-B∗57:01 in this population has not been described yet, thus, our aim was to determine the frequency of this allele in the CCVP.
Genome-wide association study links HLA allele to typhoid fever resistance
Through a genome-wide association study, an international team of researchers has identified a variant linked with resistance to typhoid fever. By examining the genomes of some 430 people with enteric fever and more than 2,000 controls, Chiea Chuen Khor from the Genome Institute of Singapore and his colleagues homed in on a marker mapping to the HLA class II region. Then using imputation-based fine-mapping, they found that an HLA-DRB1 allele contributed to resistance to typhoid, as they reported in Nature Genetics recently.
1st report on the antibody verification of MICA epitopes recorded in the HLA epitope registry
International Journal of Immunogenetics
The International Registry of HLA Epitopes has been recently established as a tool to understand antibody responses to HLA mismatches. These epitopes are defined structurally by three-dimensional molecular modelling and amino acid sequence differences between HLA antigens. A major goal was to identify HLA epitopes that have been verified experimentally with informative antibodies.
Blood test predicts signs of acute rejection in kidney transplants
Researchers at University of California, San Francisco have developed a potential test for diagnosing and predicting acute rejection in kidney transplants, a finding that eventually could replace the need for biopsies and lead to earlier detection and treatment. The study is in the Nov. 11 issue of PLOS Medicine.
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063